18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study
NCT05707182
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Recruitment was difficult.
Conditions
Prostate Cancer
Interventions
DRUG:
18F-rhPSMA-7.3
Sponsor
University of Alabama at Birmingham